Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. J. van Zanten

Publicaties

Development of an Adaptable Qualification Test Set for Personnel Involved in Visual Inspection Procedures of Parenteral Drug Products Manufactured Under Good Manufacturing Practice Conditions in Hospital Pharmacy Compounding Facilities

Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer

Roadmap for the accelerated development and clinical translation of fluorescent tracers using adalimumab-680LT

Development of a Personalized Tumor Neoantigen Based Vaccine Formulation (FRAME-001) for Use in a Phase II Trial for the Treatment of Advanced Non-Small Cell Lung Cancer

First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccine based on recombinant viral particles

Regulatory Considerations in Application of Encapsulated Cell Therapies

Biodistribution studies of epithelial cell adhesion molecule (EpCAM)-directed monoclonal antibodies in the EpCAM-transgenic mouse tumor

Fluorinated polyurethane coatings with adaptable surface properties

Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy

Pers/media

Nationaal Groeifonds investeert in UMCG-studies om ontwikkeling kankermedicijnen te versnellen